المؤلفون: Deodhar, A, Strand, V, Conaghan, P, Sullivan, E, Blackburn, S, Tian, H, Gandhi, K, Jugl, SM, Alten, R

وصف الملف: text

العلاقة: https://eprints.whiterose.ac.uk/156808/3/s41927-020-0118-z.pdfTest; Deodhar, A, Strand, V, Conaghan, P orcid.org/0000-0002-3478-5665 et al. (6 more authors) (2020) Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study. BMC Rheumatology, 4 (1). 19. ISSN 2520-1026

الإتاحة: https://eprints.whiterose.ac.uk/156808Test/
https://eprints.whiterose.ac.uk/156808/3/s41927-020-0118-z.pdfTest

المؤلفون: Coates, LC, Gladman, DD, Nash, P, FitzGerald, O, Kavanaugh, A, Kvien, TK, Gossec, L, Strand, V, Rasouliyan, L, Pricop, L, Ding, K, Jugl, SM, Gaillez, C

مصطلحات موضوعية: Clinical sciences, Immunology, Health services and systems, Public health, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Psoriatic arthritis, Secukinumab

العلاقة: Arthritis Research & Therapy; Coates, LC; Gladman, DD; Nash, P; FitzGerald, O; Kavanaugh, A; Kvien, TK; Gossec, L; Strand, V; Rasouliyan, L; Pricop, L; Ding, K; Jugl, SM; Gaillez, C, Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study, Arthritis Research & Therapy, 2018, 20 (1), pp. 272; http://hdl.handle.net/10072/399818Test

الإتاحة: https://doi.org/10.1186/s13075-018-1773-yTest
http://hdl.handle.net/10072/399818Test